Skip to content

Veradermics

US · MANE #2148 by market cap Listed 2026
119.52 -4.87 -3.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Price chart

Pre-market 121.58 -2.26%
After-hours 118.49 -0.86%
Overnight 124.26 -0.10%
156.5690.32119.522026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MANE?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +13.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 8.1% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -7.82%
1M -5.97%
3M +13.48%
6M +13.48%

Key statistics

Price & volume

Prev close
124.39
Open
121.98
Day range
118.99 - 124.00
Avg price
120.43
Volume
375.00K
Turnover
45.16M
Amplitude
4.03%
52-week range
32.00 - 156.63

Valuation

P/E
-53.52
P/E (TTM)
-49.08
P/B
6.33
EPS
-2.23
Net profit
-94.22M
Net assets
796.48M

Share structure

Market cap
5.04B
Float cap
3.86B
Shares out
42.20M
Float shares
32.25M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-02-04
52-week range 70% of range
32.00 156.63

23.7% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+41.08M net over the window

Short interest

Shares short
3.39M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Veradermics (MANE)?

Veradermics last traded at 119.52. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Veradermics's market cap?

About 5.04B.

What is the P/E ratio of Veradermics?

The trailing twelve-month P/E is -49.08. The Valuation tab shows it against the stock's own five-year range.

Does Veradermics pay a dividend?

Veradermics does not currently pay a regular dividend.

Is Veradermics a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 180.67, which implies 51.2% upside from the current price. This is not investment advice.

What is Veradermics's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Veradermics a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.

Veradermics discussion 0 comments

Add a comment